Delanzomib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Delanzomib, covering 2016-04-11 to 2023-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]